JimenezPTatsuiCJessopAThosaniS, et al.Treatment for malignant pheochromocytomas and paragangliomas: 5 years of progress. Curr Oncol Rep. 2017;19(12):83.
2.
BoettcherLBAbou-Al-ShaarHRavindraVM, et al.Intracranial epidural metastases of adrenal pheochromocytoma: a rare entity. World Neurosurg. 2018;114:235–240.
3.
LiuSSongAZhouX, et al.Malignant pheochromocytoma with multiple vertebral metastases causing acute incomplete paralysis during pregnancy: Literature review with one case report. Medicine (Baltimore). 2017;96(44):e8535.
4.
BravoEL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 1994;15(3):356–368.
5.
BaguetJPHammerLMazzucoTL, et al.Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 2004;150(5):681–686.
6.
HamidiOYoungWFJrIñiguez-ArizaNM, et al.Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102(9):3296.
7.
ColletFJ. Sur un nouveau syndrome paralytique pharyngo-larynge par blessure de guerre (hemiplegie glosso-laryngo-scapulo-pharyngee). Lyon Med. 1915;124:121–129.
8.
PrashantRFranksA. Collet-Sicard syndrome—a report and review. Lancet Oncol. 2003;4(6):376–377.
9.
NeoSLeeKE. Collet-Sicard syndrome: a rare but important presentation of internal jugular vein thrombosis. Pract Neurol. 2017;17(1):63–65.
10.
MeiLKhuranaAAl-JuhaishiT, et al.Prognostic factors of malignant pheochromocytoma and paraganglioma: a combined SEER and TCGA databases review. Horm Metab Res. 2019;51(7):451–457.
